A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Neuro-Oncology

• Publication date

  2003-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/NEUONC/5.2.79PMID 12672279PMCID PMC1920672
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Factors affecting the extension of peritumoural brain oedema. A CT-study

  2005cited by this paper
• Phase I studies of treatment of malignant gliomas and neoplastic meningitis with131I-radiolabeled monoclonal antibodies anti-tenascin 81C6 and anti-chondroitin proteoglycan sulfate Me1-14 F (ab′)2-a preliminary report

  2005cited by this paper
• World Health Organization Classification of Tumours

  2002cited by this paper
• Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials.

  2002cited by this paper
• Pathology and Genetics of Tumours of the Nervous System (World Health Organization Classification of Tumours).

  2001cited by this paper
• Clinical trial end points in malignant glioma: need for effective trial design strategy.

  2000influential reference
• Gene therapy for brain tumors

  2000cited by this paper
• A Phase III Clinical Evaluation of Herpes Simplex Virus Type 1 Thymidine Kinase and Ganciclovir Gene Therapy as an Adjuvant to Surgical Resection and Radiation in Adults with Previously Untreated Glioblastoma Multiforme

  2000cited by this paper
• Biology and treatment of malignant glioma.

  2000cited by this paper
• Pathology and genetics of tumours of the nervous system.

  2000cited by this paper
• Local control of gliomas: the next best step--a good step?

  1999cited by this paper
• Intratumoral infusion of the monoclonal antibody, mAb 425, against the epidermal-growth-factor receptor in patients with advanced malignant glioma

  1997cited by this paper
• Local application of radiolabeled monoclonal antibodies in the treatment of high grade malignant gliomas

  1997cited by this paper
• Interstitial chemotherapy with carmustine-loaded polymers for high-grade gliomas: a randomized double-blind study.

  1997cited by this paper
• Adoptive immunotherapy of malignant glioma using tumor-sensitized T lymphocytes.

  1997cited by this paper
• Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells

  1997cited by this paper
• Management of malignant brain tumors.

  1997cited by this paper
• Act locally, think globally

  1997cited by this paper
• Technetium-MIBI as a glioma imaging agent for the assessment of multi-drug resistance.

  1997cited by this paper
• Tumor regression with regional distribution of the targeted toxin TF-CRM107 in patients with malignant brain tumors

  1997cited by this paper
• Glioma invasion in the central nervous system.

  1996cited by this paper
• Bystander killing of cancer cells by herpes simplex virus thymidine kinase gene is mediated by connexins.

  1996cited by this paper
• Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain Tumor Treatment Group.

  1995cited by this paper
• Tumor-specific anti-epidermal growth factor receptor variant III monoclonal antibodies: use of the tyramine-cellobiose radioiodination method enhances cellular retention and uptake in tumor xenografts.

  1995cited by this paper
• Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas

  1995influential reference
• Convection-enhanced distribution of large molecules in gray matter during interstitial drug infusion.

  1995cited by this paper
• Gene Therapy for Brain Tumors

  1995cited by this paper
• The value of cytoreductive surgery.

  1994cited by this paper
• The chemotherapy of high-grade astrocytomas.

  1994cited by this paper
• Biodegradable polymers for controlled delivery of chemotherapy with and without radiation therapy in the monkey brain.

  1994cited by this paper
• The effect of transforming growth factor-beta 2-specific phosphorothioate-anti-sense oligodeoxynucleotides in reversing cellular immunosuppression in malignant glioma.

  1993cited by this paper
• Meta‐analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults

  1993cited by this paper
• Chemotherapy of gliomas.

  1992cited by this paper
• A randomized comparison of intra-arterial versus intravenous BCNU, with or without intravenous 5-fluorouracil, for newly diagnosed patients with malignant glioma.

  1992cited by this paper
• Modulation of the immune response by transforming growth factor beta.

  1992cited by this paper
• In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors.

  1992cited by this paper
• Superselective intraarterial cisplatin application for recurrent malignant gliomas

  1992cited by this paper
• Aggressive oligodendroglioma: a chemosensitive tumor.

  1992cited by this paper
• Aggressive oligodendroglioma: a chemosensitive tumor.

  1992cited by this paper
• Lymphokine-activated killer cells, interleukin-2 and tumour necrosis factor α in malignant glioma : clinical and laboratory findings

  1991cited by this paper
• Immunotherapy for malignant glioma using human recombinant interleukin-2 and activated autologous lymphocytes

  1990cited by this paper
• Cancer : Principles and Practice of Oncology

  1982cited by this paper
• Assumptions in the radiotherapy of glioblastoma

  1980cited by this paper
• Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery.

  1980cited by this paper
• Neoplasms of the central nervous system.

  1977cited by this paper

• Bridging the blood-brain barrier: strategies to improve delivery of biologics to tumors in the brain

  2026cites this paper
• Predictors of Survival in Patients Aged ≥70 with Glioblastoma: A Time-Dependent Multivariable Analysis

  2026cites this paper
• Intraparenchymal Occipital Cyst Formation after Contralateral Dural Arteriovenous Fistula Obliteration: A Case Report

  2026cites this paper
• The role of ASIC2 in glioma progression: implications for prognosis and therapeutic targeting

  2026cites this paper
• Impact of Carmustine wafer implantation in epileptic seizures of newly diagnosed glioblastomas, IDH-wildtype in adults

  2026cites this paper
• Injectable thermo-responsive hydrogel scaffold for enhanced delivery of second-generation induced neural stem cells for treatment of glioblastoma

  2026cites this paper
• Frontiers and challenges in brain drug delivery: Emerging nanotechnology approaches to overcome the blood-brain barrier for neurodegenerative disease treatment

  2026cites this paper
• Beyond the dose: a clearance-enabled in vitro platform for evaluating local therapies.

  2026cites this paper
• Challenges and material innovations in drug delivery to central nervous system tumors.

  2025cites this paper
• Applications and Efficacy of Iron Oxide Nanoparticles in the Treatment of Brain Tumors

  2025cites this paper
• Postoperatively injected gel with sequential delivery of platinum agents to synergize with radiotherapy for suppressing high-grade glioma relapse

  2025cites this paper
• Mechanically robust neuroprotective stent by sequential Mg ions release for ischemic stroke therapy

  2025cites this paper
• Glioblastoma: From Pathophysiology to Novel Therapeutic Approaches

  2025influential citation
• Overall survival after carmustine wafers implantation for newly-diagnosed high grade glioma. A nationwide population-based controlled propensity score-matched analysis.

  2025cites this paper
• Cancer neuroscience and glioma: clinical implications

  2025cites this paper
• Engineered nanoparticles as a promising drug delivery system for glioblastoma multiforme treatment.

  2025cites this paper
• Engineering therapeutics for glioma: Multiscale drug delivery strategies from in-situ drug depots to advanced systemic approaches

  2025cites this paper
• Overcoming the Blood-Brain Barrier for Drug Delivery to the Brain

  2025cites this paper
• Rational hydrogel design to improve brain modulus matching for implantation

  2025cites this paper
• Carmustine Wafers (Gliadel) in Brain Metastases: Revisiting an Old Concept With New Insights

  2025cites this paper
• Vortioxetine: A Potential Drug for Repurposing for Glioblastoma Treatment via a Microsphere Local Delivery System

  2025cites this paper
• Advancing Glioma Management: The Pivotal Role of Surgical Neuro-Oncology in Driving Innovation and Translational Research

  2025cites this paper
• A comprehensive review on roles of electrochemical approaches in drug delivery

  2025cites this paper
• Local Drug Delivery Systems for Cancer Therapy

  2025cites this paper
• Critical regulatory roles of non-coding RNAs in driving cancer sensitivity to Carmustine: a systematic review

  2025cites this paper
• Targeting the glioblastoma resection margin with locoregional nanotechnologies

  2025cites this paper
• Comprehensive review on glioblastoma: nanotechnology, immunotherapy and combined therapeutic approaches

  2025cites this paper
• Improving glioblastoma treatment with imaging, radiotherapy, drug delivery, and therapeutic systems

  2025cites this paper
• Advancing Glioblastoma Therapy: Learning From the Past and Innovations for the Future.

  2025cites this paper
• Therapeutic Targets in Glioblastoma: Molecular Pathways, Emerging Strategies, and Future Directions

  2025cites this paper
• How I do it: > 8 Carmustine wafer implantation during supra-marginal resection of a glioblastoma, IDH-wildtype

  2025cites this paper
• Translational advancements in tumor vaccine therapies for glioblastomas

  2025cites this paper
• 3D printed biodegradable bilayer films: a promising frontier in liver cancer therapy

  2025cites this paper
• From Screening to a Nanotechnological Platform: Cannabidiol–Chemotherapy Co-Loaded Lipid Nanocapsules for Glioblastoma Multiforme Treatment

  2025cites this paper
• The effects of the combination therapy of chemotherapy drugs on the fluctuations of genes involved in the TLR signaling pathway in glioblastoma multiforme therapy.

  2024cites this paper
• Solvent effect, spectral (SERS and UV-Vis) and adsorption analysis of Gliadel (GL) anticancer drug with Ag/Au loaded silica nanocomposites

  2024cites this paper
• Clinical Course after Carmustine Wafer Implantation for Newly Diagnosed Adult-type Diffuse Gliomas; A controlled propensity matched analysis of a single center cohort

  2024influential citation
• Effect of Intraoperative Ventricular Opening on Recurrence Patterns Following Bis-Chloroethyl-Nitrosourea Wafer Implantation for Newly Diagnosed Glioblastoma

  2024cites this paper
• Overcoming Barriers in Glioblastoma—Advances in Drug Delivery Strategies

  2024cites this paper
• Cases Report on Innovative Drug-Delivery System Containing Paclitaxel for Treating Canine Gliomas

  2024cites this paper
• The road after cancer: biomaterials and tissue engineering approaches to mediate the tumor microenvironment post-cancer treatment

  2024cites this paper
• In Reply: Efficacy and Safety of Carmustine Wafer Implantation After Ventricular Opening in Glioblastomas, Isocitrate Dehydrogenase-Wildtype, in Adults.

  2024cites this paper
• Glioblastoma Therapy: Past, Present and Future

  2024cites this paper
• Cell-Penetrating Peptides-Mediated Therapeutic Agents Delivery into the Central Nervous System

  2024cites this paper
• Peritumoral brain zone in glioblastoma: biological, clinical and mechanical features

  2024cites this paper
• Microneedle patch capable of dual drug release for drug delivery to brain tumors

  2024influential citation
• Toxicology study of a tissue anchoring paclitaxel prodrug

  2024cites this paper
• Intracranial Nanogel Pellets Carrying Temozolomide and Paclitaxel for Adjuvant Brain Cancer Therapy.

  2024cites this paper
• Cerebral Glioblastoma in Renal Transplant Recipient: A Case Report

  2024cites this paper
• Local administration of irinotecan using an implantable drug delivery device stops high-grade glioma tumor recurrence in a glioblastoma tumor model

  2024influential citation
• Neurosurgical application of olaparib from a thermo-responsive paste potentiates DNA damage to prolong survival in malignant glioma

  2024cites this paper
• Antioxidant Enzymes in Cancer Cells: Their Role in Photodynamic Therapy Resistance and Potential as Targets for Improved Treatment Outcomes

  2024cites this paper
• Leveraging next-generation materials for cancer neuroscience therapies in the central nervous system

  2024cites this paper
• Efficacy of interstitial photodynamic therapy using talaporfin sodium and a semiconductor laser for a mouse allograft glioma model

  2024cites this paper
• Lipidomics-driven drug discovery and delivery strategies in glioblastoma.

  2024cites this paper
• Precision medicine focus on the central nervous system: Non-invasive therapeutic agent delivery with focused ultrasound and microbubbles.

  2024cites this paper
• Is Carmustine Wafer Implantation in Progressive High-Grade Gliomas a Relevant Therapeutic Option? Complication Rate, Predictors of Complications and Onco-Functional Outcomes in a Series of 53 Cases

  2024cites this paper
• Unmanageable Cerebrospinal Fluid Leakage With Eosinophilic Meningitis in a Gliadel Wafer Implant Patient

  2024cites this paper
• Astrocitoma di alto grado e glioblastoma

  2024cites this paper
• Targeted Glioma Therapy—Clinical Trials and Future Directions

  2024cites this paper
• Comprehensive insights into glioblastoma multiforme: drug delivery challenges and multimodal treatment strategies.

  2024cites this paper
• The Case for Neurosurgical Intervention in Cancer Neuroscience

  2024cites this paper
• Glioblastoma multiforme - a rare type of cancer: A narrative review

  2024cites this paper
• Understanding the Genomic Landscape of Glioblastoma: Opportunities for Targeted Therapies

  2024cites this paper
• Efficacy and safety of carmustine wafers, followed by radiation, temozolomide, and bevacizumab therapy, for newly diagnosed glioblastoma with maximal resection

  2024cites this paper
• A new nano approach to prevent tumor growth in the local treatment of glioblastoma: Temozolomide and rutin-loaded hybrid layered composite nanofiber

  2024cites this paper
• Local dose-dense chemotherapy for triple-negative breast cancer via minimally invasive implantation of 3D printed devices

  2024cites this paper
• Efficacy and Safety of Carmustine Wafer Implantation After Ventricular Opening in Glioblastomas, Isocitrate Dehydrogenase-Wildtype, in Adults

  2024cites this paper
• Doxorubicin-loaded liposome-like particles embedded in chitosan/hyaluronic acid-based hydrogels as a controlled drug release model for local treatment of glioblastoma.

  2024cites this paper
• Insights into Targeted and Stimulus‐Responsive Nanocarriers for Brain Cancer Treatment

  2024cites this paper
• Local Delivery of Irinotecan to Recurrent GBM Patients at Reoperation Offers a Safe Route of Administration

  2024cites this paper
• Using a Pre-Radiation Window to Identify Potentially Active Cytotoxic Agents in Adults with Newly Diagnosed Glioblastoma.

  2024cites this paper
• Cost of medical care for malignant brain tumors at hospitals in the Japan Clinical Oncology Group brain-tumor study group

  2024cites this paper
• Microneedle Patch Delivery of PLCG1-siRNA Efficient Enhanced Temozolomide Therapy for Glioblastoma.

  2024cites this paper
• Astrocytome de haut grade et glioblastome

  2024cites this paper
• Advancements in Drug Delivery Systems: A Focus on Microsphere-Based Targeted Delivery

  2024cites this paper
• Impact of tumor-treating fields on the survival of Japanese patients with newly diagnosed glioblastoma: A multicenter, retrospective cohort study

  2024cites this paper
• Surgical Management and Advances in the Treatment of Glioma

  2023cites this paper
• Implantable microdevices for treating brain tumors

  2023cites this paper
• Biology-driven material design for ischaemic stroke repair

  2023cites this paper
• Intraoperative and postoperative complications for repeat high-grade glioma resections with concurrent chemotherapy: patient series

  2023cites this paper
• Injectable nanogel systems for brain drug delivery

  2023cites this paper
• Investigational treatment strategies in glioblastoma: progress made and barriers to success

  2023cites this paper
• Drug-Loaded Lipid Magnetic Nanoparticles for Combined Local Hyperthermia and Chemotherapy against Glioblastoma Multiforme

  2023cites this paper
• A Comprehensive Review on Current Treatments and Challenges Involved in the Treatment of Ovarian Cancer.

  2023cites this paper
• Role of Oxidative Stress in Metabolic Reprogramming of Brain Cancer

  2023cites this paper
• Cell primitive-based biomimetic nanomaterials for Alzheimer's disease targeting and therapy

  2023cites this paper
• Lawn grasses and their method of establishment: A review

  2023influential citation
• Novel therapeutic strategies in glioma targeting glutamatergic neurotransmission.

  2023cites this paper
• Anti-Melanoma Activity of Single Intratumoral Injection of ZnPc Micelles Mixed With in situ Gel in B16 Bearing Mouse.

  2023cites this paper
• Local administration of shikonin improved the overall survival in orthotopic murine glioblastoma models with temozolomide resistance.

  2023cites this paper
• Nose-to-brain drug delivery: Challenges and progress towards brain targeting in the treatment of neurological disorders

  2023cites this paper
• Machine learning to improve interpretability of clinical, radiological and panel-based genomic data of glioma grade 4 patients undergoing surgical resection

  2023cites this paper
• Malignant Glioma.

  2023cites this paper
• Carmustine wafer implantation for supratentorial glioblastomas, IDH-wildtype in “extreme” neurosurgical conditions

  2023cites this paper
• Emerging frontiers in drug delivery with special focus on novel techniques for targeted therapies.

  2023cites this paper
• Porous hydroxyapatite carrier enables localized and sustained delivery of honokiol for glioma treatment.

  2023cites this paper
• Nanobiotechnology-based treatment strategies for malignant relapsed glioma.

  2023cites this paper
• Long-Acting Therapeutic Delivery Systems for the Treatment of Gliomas.

  2023cites this paper
• Current advances in temozolomide encapsulation for the enhancement of glioblastoma treatment

  2023cites this paper